Phase 2 Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with active rheumatoid arthritis based on recognised classification standards set in 2010.
- People whose disease activity score across 28 joints (a standard measurement of rheumatoid arthritis severity) is above 2.6, indicating the condition is not well controlled.
- People aged between 18 and 60 years.
- Both men and women are included.
- People who are currently taking methotrexate alongside other standard treatments for their condition.
- People who are able to read and sign a written consent form agreeing to take part.
Who may not be able to join:
- People who have kidney or liver disease.
- People who have a known allergy or sensitivity to the medications used in this trial.
- People who are currently taking antioxidant supplements.
- People who have a history of psychiatric (mental health) conditions.
- People who are taking the steroid prednisolone by mouth at a dose higher than 15 mg per day.
- People who are currently being treated with biological medicines for their arthritis (a specific type of advanced medication).
- People who are pregnant or breastfeeding.
- People who have a history of irregular heartbeat or a heart condition known as prolonged QT interval (confirm with trial site).
- People who are taking any medications known to affect the heart's electrical rhythm (prolonged QT interval) (confirm with trial site for specific medicines this includes).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Amira Mashaly, Horus University
Phone: 01028275001
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Disease Activity Score (DAS28)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.